Bank of Nova Scotia
KRTX

Bank of Nova Scotia’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Bank of Nova Scotia’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-119,810
Closed -$37.9M – 1073
2023
Q4 		$37.9M Buy
+119,810
New +$23.3M 0.07% 196

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Bank of Nova Scotia's KRTX Position: Q1 2024 in Review

Bank of Nova Scotia sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 119,810 shares — an estimated $37.9M sold.

Bank of Nova Scotia first reported a position in KRTX in Q4 2023 and held it in 1 quarter. The position peaked at $37.9M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Bank of Nova Scotia reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Bank of Nova Scotia sold 119,810 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $37.9M.
  • Bank of Nova Scotia first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
  • Bank of Nova Scotia's Karuna Therapeutics, Inc. Common Stock position peaked at $37.9M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Bank of Nova Scotia's 13F filing for Q1 2024, filed 15 May 2024.